Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The therapeutic potential of green synthesized zinc oxide nanoparticles in murine schistosomiasis.

Parasites, hosts and diseases·2026
Same author

The therapeutic potential of atorvastatin in treatment of <i>G. lamblia</i> infected mice; <i>in silico</i>, parasitological, and histopathological study.

Frontiers in veterinary science·2026
Same author

Vitamin D: a potential therapeutic for giardiasis in experimentally infected mice.

Scientific reports·2026
Same author

Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor.

Cell reports·2026
Same author

The role of suPAR and related proteins in kidney, heart diseases, and diabetes.

The Journal of clinical investigation·2026
Same author

Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis.

Cell·2025

Related Experiment Video

Updated: Apr 15, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.8K

A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.

Ha Won Lee1, Samia Q Khan1, Mohd Hafeez Faridi1

  • 1Department of Medicine, Rush University Medical Center, Chicago, Illinois;

Journal of the American Society of Nephrology : JASN
|April 11, 2015
PubMed
Summary

Researchers developed a new assay to screen for drugs protecting podocytes, crucial cells in kidney health. They identified pyrintegrin, a compound that shields podocytes from injury and reduces proteinuria in animal models, offering a potential therapeutic for kidney diseases.

Keywords:
adhesion moleculeglomerular diseaseglomerular epithelial cells

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.7K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.6K

Related Experiment Videos

Last Updated: Apr 15, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.8K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.7K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.6K

Area of Science:

  • Nephrology
  • Cell Biology
  • Drug Discovery

Background:

  • Podocyte injury is central to glomerular diseases.
  • Effective therapeutics targeting podocytes are needed.
  • Current high-throughput screening assays for podocyte-directed drugs are lacking.

Purpose of the Study:

  • To develop and validate a novel high-content screening assay for identifying podocyte-protective agents.
  • To identify small molecules that protect podocytes from injury using the developed assay.
  • To evaluate the therapeutic potential of identified compounds in preclinical models of proteinuric kidney diseases.

Main Methods:

  • Developed a high-content phenotypic screening assay in 96-well plates for podocyte injury.
  • Screened over 2100 pharmacologically active agents for podocyte protection.
  • Validated lead compounds, including a β1-integrin agonist (pyrintegrin), in vitro and in vivo models (LPS-induced injury in mice, puromycin aminonucleoside nephropathy in rats).

Main Results:

  • The assay demonstrated high reproducibility (Z' >0.44) and identified 24 protective small molecules (1% hit rate).
  • Pyrintegrin treatment preserved F-actin stress fibers and focal adhesions, and maintained active β1-integrin levels in cultured podocytes.
  • In vivo, pyrintegrin prevented LPS-induced podocyte effacement and proteinuria in mice, and reduced proteinuria in rats.

Conclusions:

  • A novel, robust high-content screening assay for podocyte-directed therapeutics was established.
  • Pyrintegrin is identified as a promising therapeutic candidate for proteinuric kidney diseases due to its podocyte-protective effects.
  • This screening approach facilitates the discovery of novel treatments for glomerular diseases.